https://www.selleckchem.com/products/e6446.html
5,069 (25%) PLWH initiated INSTI-based regimens. 203 MACE events occurred; acute MI 16 (0.32%) vs 66 (0.43%), stroke 24 (0.47%) vs 54 (0.36), CABG 2 (0.04%) vs 9 (0.06%), PCI 7 (0.14%) vs 25 (0.16%) of INSTI users vs non-users. INSTI-based ART was associated with significantly lower risk of MACE events (HR 0.79; 95% CI 0.64, 0.96) compared to non-INSTI-based regimens. CONCLUSION In this cohort, INSTI-based regimens were associated with a 21% decreased risk of incident CVD. These finding require validation in other cohorts and with longer
Like
Comment
Share
